Abstract
Intestinal acute GVHD (I-aGVHD) is a life-threatening complication after allografting. Non-invasive bed-side procedures to evaluate extension and treatment response are still lacking. We hypothesized that, during I-aGVHD, contrast-enhanced ultrasound sonography (CEUS) could detect microcirculation changes (MVC) of the bowel wall (BW) and help to monitor treatment response. We prospectively employed CEUS in 83 consecutive patients. Of these, 14 patients with biopsy-proven intestinal GVHD (I-GVHD) were defined as the study group, whereas 16 patients with biopsy-proven stomach GVHD (U-GVHD) without intestinal symptoms, 6 normal volunteers and 4 patients with neutropenic enterocolitis were defined as the control group. All patients were evaluated with both standard ultrasonography (US) and CEUS at the onset of intestinal symptoms, during clinical follow-up and at flare of symptoms. Standard US revealed BW thickening of multiple intestinal segments, useful to determine the extension of GVHD. CEUS showed MVC, which correlated with GVHD activity, treatment response, and predicted flare of intestinal symptoms. US and CEUS findings were superimposable at diagnosis and in remission. CEUS was, however, more sensitive and specific to identify subclinical activity in patients with clinical relevant improvement. These findings were not observed in the control groups. CEUS is a non-invasive, easily reproducible bed-side tool useful to monitor I-aGVHD.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
McDonald GB, Shulman HM, Sullivan KM, Spencer GD . Intestinal and hepatic complications of human bone marrow transplantation. Part I. Gastroenterology 1986; 90: 460–477.
McDonald GB, Shulman HM, Sullivan KM, Spencer GD . Intestinal and hepatic complications of human bone marrow transplantation. Part II. Gastroenterology 1986; 90: 770–784.
Sale GE, Shulman HM, McDonald GB, Thomas ED . Gastrointestinal graft-versus-host disease in man. A clinicopathologic study of the rectal biopsy. Am J Surg Pathol 1979; 3: 291–299.
Fisk JD, Shulman HM, Greening RR, McDonald GB, Sale GE, Thomas ED . Gastrointestinal radiographic features of human graft-vs.-host disease. Am J Roentgenol 1981; 136: 329–336.
Klein SA, Martin H, Schreiber-Dietrich D, Hermann S, Caspary WF, Hoelzer D et al. A new approach to evaluating intestinal acute graft-versus-host disease by transabdominal sonography and colour Doppler imaging. Br J Haematol 2001; 115: 929–934.
Görg C, Wollenberg B, Beyer J, Stolte MS, Neubauer A . High-resolution ultrasonography in gastrointestinal graft-versus-host disease. Ann Hematol 2005; 84: 33–39.
Haber HP, Schlegel PG, Dette S, Ruck P, Klingebiel T, Niethammer D . Intestinal acute graft-versus-host disease: findings on sonography. Am J Roentgenol 2000; 174: 118–120.
Cammarota T, Sarno A, Robotti D, Bonenti G, Debani P, Versace K et al. US evaluation of patients affected by IBD: how to do it, methods and findings. Eur J Radiol 2009; 69: 429–437.
Robotti D, Cammarota T, Debani P, Sarno A, Astegiano M . Activity of Crohn disease: value of Color-Power-Doppler and contrast-enhanced ultrasonography. Abdom Imaging 2004; 29: 648–652.
Gritzmann N, Hollerweger A, Macheiner P, Rettenbacher T . Transabdominal sonography of the gastrointestinal tract. Eur Radiol 2002; 12: 1748–1761.
Maconi G, Imbesi V, Bianchi Porro G . Doppler ultrasound measurement of intestinal blood flow in inflammatory bowel disease. Scand J Gastroenterol 1996; 31: 590–593.
Giovagnorio F, Diacinti D, Vernia P . Doppler sonography of the superior mesenteric artery in Crohn’s disease. Am J Roentgenol 1998; 170: 123–126.
Ludwig D, Wiener S, Brüning A, Schwarting K, Jantschek G, Stange EF . Mesenteric blood flow is related to disease activity and risk of relapse in Crohn’s disease: a prospective follow-up study. Am J Gastroenterol 1999; 94: 2942–2950.
Mayer D, Reinshagen M, Mason RA, Muche R, von Tirpitz C, Eckelt D et al. Sonographic measurement of thickened bowel wall segments as a quantitative parameter for activity in inflammatory bowel disease. Z Gastroenterol 2000; 38: 295–300.
Penack O, Socié G, Van den Brink MRM . The importance of neovascularization and its inhibition for allogeneic hematopoietic stem cell transplantation. Blood 2011; 117: 4181–4189.
Benedetti E, Caracciolo F, Papineschi F, Bruno B, McDonald GB, Pelosini M et al. Contrast enhanced ultrasound sonography in intestinal acute graft-versus-host disease. Bone Marrow Transplant 2009; 43: S367–S367.
Schreyer AG, Landfried K, Zorger N, Hoffstetter P, Ammer J, Fellner C et al. Transmural penetration of intravenously applied microbubbles during contrast-enhanced ultrasound as a new diagnostic feature in patients with GVHD of the bowel. Bone Marrow Transplant 2011; 46: 1006–1011.
Schreyer AG, Landfried K, Jung EM, da Silva NPB, Poschenrieder F, Dornia C et al. Contrast-enhanced ultrasound for differential diagnosis of suspected GvHD in patients after allogeneic transplantation. Clin Hemorheol Microcirc 2011; 49: 129–136.
Maconi G, Parente F, Bollani S, Cesana B, Bianchi Porro G . Abdominal ultrasound in the assessment of extent and activity of Crohn’s disease: clinical significance and implication of bowel wall thickening. Am J Gastroenterol 1996; 91: 1604–1609.
Klein SA, Martin H, Schreiber-Dietrich D, Hermann S, Caspary WF et al. A new approach to evaluating intestinal acute graft-versus-host disease by transabdominal sonography and colour Doppler imaging. Br J Haematol 2001; 115: 929–934.
Piscaglia F, Nolsøe C, Dietrich CF, Cosgrove DO, Gilja OH, Bachmann M et al. The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications. Ultraschall Med 2012; 1: 33–59.
Ertault-Daneshpouy M, Leboeuf C, Lemann M, Bouhidel F, Ades L, Gluckman E et al. Pericapillary hemorrhage as criterion of severe human digestive graft-versus-host disease. Blood 2004; 103: 4681–4684.
Pullinger BD, Florey HW . Some observations on the structure and functions of lymphatics: their behavior in local edema. J Exp Pathol 1935; 16: 49–61.
Di Sabatino A, Fulle I, Ciccocioppo R, Ricevuti L, Tinozzi FP, Tinozzi S et al. Doppler enhancement after intravenous levovist injection in Crohn’s disease. Inflamm Bowel Dis 2002; 8: 251–257.
Serra C, Menozzi G, Labate AM, Giangregorio F, Gionchetti P, Beltrami M et al. Ultrasound assessment of vascularization of the thickened terminal ileum wall in Crohn’s disease patients using a low-mechanical index real-time scanning technique with a second generation ultrasound contrast agent. Eur J Radiol 2007; 62: 114–121.
Gooley TA, Chien JW, Pergam SA, Hingorani S, Sorror ML, Boeckh M et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med 2010; 363: 2091.
Gorschlüter M, Mey U, Strehl J, Ziske C, Schepke M, Schmidt-Wolf IGH et al. Neutropenic enterocolitis in adults: systematic analysis of evidence quality. Eur J Haematol 2005; 75: 1–13.
Benedetti E, Caracciolo F, Lippolis P, Bruno B, Caramella D, Cerri F et al. Neutropenic enterocolitis: prospective study on usefulness of ultrasound sonography for early diagnosis and to guide medical or surgical treatment. Bone Marrow Transplant 2012; 47: S77.
Epstein RJ, McDonald GB, Sale GE, Shulman HM, Thomas ED . The diagnostic accuracy of the rectal biopsy in acute graft-versus-host disease: a prospective study of thirteen patients. Gastroenterology 1980; 78: 764–771.
Thomas ED, Storb R, Clift RA, Fefer A, Johnson FL, Neiman PE . Success or failure of marrow engraftment and marrow-graft rejection (second of two parts). N Engl J Med 1975; 292: 895–902.
Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945–956.
Kuzmich S, Howlett DC, Andi A, Shah D, Kuzmich T . Transabdominal sonography in assessment of the bowel in adults. Am J Roentgenol 2009; 192: 197–212.
Bolondi L, Casanova P, Santi V, Caletti G, Barbara L, Labò G . The sonographic appearance of the normal gastric wall: an in vitro study. Ultrasound Med Biol 1986; 12: 991–998.
Lim JH, Jeong YM . Sonography of the stomach: an in vitro study to determine the anatomic cause of inner hyperechoic and hypoechoic layers of the gastric wall. Am J Roentgenol 1994; 162: 335–338.
Hollerweger A . Colonic diseases: the value of US examination. Eur J Radiol 2007; 64: 239–249.
Cartoni C, Dragoni F, Micozzi A, Pescarmona E, Mecarocci S, Chirletti P et al. Neutropenic enterocolitis in patients with acute leukemia: prognostic significance of bowel wall thickening detected by ultrasonography. J Clin Oncol 2001; 19: 756–761.
Hagiu C, Badea R . Applicability of abdominal ultrasonography in inflammatory bowel disease. J Gastrointestin Liver Dis 2007; 16: 205–209.
Piscaglia F, Nolsøe C, Dietrich CF, Cosgrove DO, Gilja OH, Bachmann M et al. The EFSUMB guidelines and recommendations on the clinical practice of contrast enhanced ultrasound (CEUS): update 2011 on non-hepatic applications. Ultraschall Med 2012; 1: 33–59.
Morel DR, Schwieger I, Hohn L, Terrettaz J, Llull JB, Cornioley YA et al. Human pharmacokinetics and safety evaluation of SonoVue, a new contrast agent for ultrasound imaging. Invest Radiol 2000; 35: 80–85.
Claudon M, Cosgrove D, Albrecht T, Bolondi L, Bosio M, Calliada F et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS)—update 2008. Ultraschall Med 2008; 29: 28–44.
Quaia E, Calliada F, Bertolotto M, Rossi S, Garioni L, Rosa L et al. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 2004; 232: 420–430.
Migaleddu V, Scanu AM, Quaia E, Rocca PC, Dore MP, Scanu D et al. Contrast-enhanced ultrasonographic evaluation of inflammatory activity in Crohn’s disease. Gastroenterology 2009; 137: 43–52.
Quaia E, Migaleddu V, Baratella E, Pizzolato R, Rossi A, Grotto M et al. The diagnostic value of small bowel wall vascularity after sulfur hexafluoride-filled microbubble injection in patients with Crohn’s disease. Correlation with the therapeutic effectiveness of specific anti-inflammatory treatment. Eur J Radiol 2009; 69: 438–444.
Deeg HJ . How I treat refractory acute GVHD. Blood 2007; 109: 4119–4126.
Patriarca F, Sperotto A, Damiani D, Morreale G, Bonifazi F, Olivieri A et al. Infliximab treatment for steroid-refractory acute graft-versus-host disease. Haematologica 2004; 89: 1352–1359.
Kharfan-Dabaja MA, Cutler CS . Rituximab for prevention and treatment of graft-versus-host disease. Int J Hematol 2011; 93: 578–585.
Shimabukuro-Vornhagen A, Hallek MJ, Storb RF, von Bergwelt-Baildon MS . The role of B cells in the pathogenesis of graft-versus-host disease. Blood 2009; 114: 4919–4927.
Perfetti P, Carlier P, Strada P, Gualandi F, Occhini D, Van Lint MT et al. Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD. Bone Marrow Transplant 2008; 42: 609–617.
Ibrahim RB, Abidi MH, Cronin SM, Lum LG, Al-Kadhimi Z, Ratanatharathorn V et al. Non absorbable corticosteroids use in the treatment of gastrointestinal graft-versus-host disease. Biol Blood Marrow Transplant 2009; 15: 395–405.
Deeg HJ, Antin JH . The clinical spectrum of acute graft-versus-host disease. Semin Hematol 2006; 43: 24–31.
Bacigalupo A . Management of acute graft-versus-host disease. Br J Haematol 2007; 137: 87–98.
Thompson B, Salzman D, Steinhauer J, Lazenby AJ, Wilcox CM . Prospective endoscopic evaluation for gastrointestinal graft-versus-host disease: determination of the best diagnostic approach. Bone Marrow Transplant 2006; 38: 371–376.
Shidham VB, Chang CC, Shidham G, Ghazala F, Lindholm PF, Kampalath B et al. Colon biopsies for evaluation of acute graft-versus-host disease (A-GVHD) in allogeneic bone marrow transplant patients. BMC Gastroenterol 2003; 3: 5.
Stelljes M, Hermann S, Albring J, Köhler G, Löffler M, Franzius C et al. Clinical molecular imaging in intestinal graft-versus-host disease: mapping of disease activity, prediction, and monitoring of treatment efficiency by positron emission tomography. Blood 2008; 111: 2909–2918.
Katzberg RW, Haller C . Contrast-induced nephrotoxicity: clinical landscape. Kidney Int Suppl 2006; 69: S3–S7.
Acknowledgements
We thank the nurses and medical staff for caring for the patients.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Benedetti, E., Bruno, B., McDonald, G. et al. Prospective qualitative and quantitative non-invasive evaluation of intestinal acute GVHD by contrast-enhanced ultrasound sonography. Bone Marrow Transplant 48, 1421–1428 (2013). https://doi.org/10.1038/bmt.2013.65
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2013.65
Keywords
This article is cited by
-
Acute graft-versus-host disease
Nature Reviews Disease Primers (2023)
-
PET assessment of acute gastrointestinal graft versus host disease
Bone Marrow Transplantation (2023)
-
Bowel wall thickness is a strong predictor of steroid-refractory acute graft-versus-host disease with gut involvement after allo-HSCT
International Journal of Hematology (2022)
-
Role of contrast-enhanced ultrasound in evaluation of the bowel
Abdominal Radiology (2018)
-
Acute graft-versus-host disease of the gut: considerations for the gastroenterologist
Nature Reviews Gastroenterology & Hepatology (2017)